Logo
MIDDLE EAST AND TURKEY HEMOPHILIA TREATMENT MARKET ANALYSIS
  2. / Market Insights
  3. Middle East And Turkey Hemophilia Treatment Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

MIDDLE EAST AND TURKEY HEMOPHILIA TREATMENT MARKET ANALYSIS

Middle East and Turkey Hemophilia Treatment Market, By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Desmopressin), By Disease Indication (Hemophilia A, Hemophilia B, and Hemophilia C), and By Country (Turkey, Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East)-

  • Published In : Apr 2023
  • Code : CMI3250
  • Pages :230
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Middle East And Turkey Hemophilia Treatment MarketSize and Trends

Middle East and Turkey Hemophilia Treatment Marketis estimated to be valued at US$ 756.0 Million in 2023, exhibiting a CAGR of 4.5% during the forecast period (2023-2030).

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Middle East And Turkey Hemophilia Treatment Market To Surpass US$ 1,031.5 Mn By 2030
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.